GENE ONLINE|News &
Opinion
Blog

bluebird bio
FDA Investigates Reports of Blood Cancer Cases Linked to Gene Therapy
2024-12-02
Will Breakthrough Therapy Lead the Way? An Overview of the Approved Gene and Cell Therapies for 2022
2023-01-13
Bluebird’s Rare Childhood Neurodegenerative Gene Therapy Gains Accelerated Approval
2022-09-19
Bluebird Bio’s Zynteglo Becomes First FDA-Approved Gene Therapy For Beta-Thalassemia
2022-08-18
ARM 2022: Industry Briefs on Cell and Gene Therapies
2022-01-17
FDA Grants Priority Review for bluebird bio’s β-Thalassemia Gene Therapy
2021-11-23
Resilience Acquires Bluebird Bio’s Manufacturing Facility to Develop Next Gen Cell Therapies
2021-07-31
BMS, bluebird’s Multiple Myeloma Drug Becomes First BCMA Targeting CAR-T Therapy to Snag FDA Okay
2021-03-28
Bluebird Bio Temporarily Suspends Sickle Cell Trials Following Cancer Diagnosis in Two Patients
2021-02-18
BMS, bluebird bio’s Investigational BCMA CAR-T Therapy Faces Regulatory Setback
2020-05-18
LATEST
AI-Powered Blood Test Achieves 98% Accuracy in Early Breast Cancer Detection
2024-12-11
Taiwan’s Vice President Hsiao Bi-Khim Advocates Innovations in Medtech, Biotech, and Healthtech
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part II
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part I
2024-12-11
Healthcare Revolution: Leeuwenhoek Joins Hands with Key Companies and Experts at Healthcare+ Expo Taiwan 2024
2024-12-11
Protect Animal Health and Rejuvenate Bio Partner to Tackle Canine Heart Disease
2024-12-11
2024 Taiwan Healthcare+ Expo: Innovations in Five Key Industries
2024-12-11
EVENT
Scroll to Top